Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, CMV is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of CMV disease. An indicator of active CMV infection is needed to facilitate the diagnosis of CMV disease in patients with AIDS or HIV infection. CMV p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.
Host
Mouse
Immunogen
Recombinant CMV-p65 protein
Positive Control
CMV-infected cells or tissues.
Reactivity
CMV
Recombinant
FALSE
Regulatory
RUO
Swissprot
Not Applicable
Uniprot
Not Applicable
Gene Id
Not Applicable
Buffer
200μg/ml of Ab purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA; 0.05% azide. Also available WITHOUT BSA at 1.0mg/ml.
Concentration
1.0mg/ml
Description
There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.
Purity
Purified Ab WITHOUT BSA at 1.0mg/ml
Applications
ELISA, IHC(af), IF
Description
Optimal dilution for a specific application should be determined., ELISA ; IHC(af) ; IF
Dilution
ELISA
For coating, order Ab without BSA
IHC(af)
0.5-1μg/ml for 30 min
IF
0.5-1μg/ml
Reviews of Anti-Cytomegalovirus p65 (CMV-p65) Antibody BHA10207411